Barclays’s SYMMETRY MEDICAL INC SMA Stock Holding History

Barclays’s Portfolio SMA Stock Details SMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-9,676	Closed	-$97K	–	7953
2014 Q3	$97K	Buy	9,676 +6	+0.1%	+$56	﹤0.01%	5361
2014 Q2	$78K	Buy	9,670 +2,684	+38%	+$23.4K	﹤0.01%	5622
2014 Q1	$71K	Sell	6,986 -46,725	-87%	-$466K	﹤0.01%	5719
2013 Q4	$537K	Sell	53,711 -7,021	-12%	-$61.1K	﹤0.01%	4025
2013 Q3	$486K	Buy	60,732 +10,600	+21%	+$89.7K	﹤0.01%	4150
2013 Q2	$422K	Buy	+50,132	New	+$515K	﹤0.01%	4413

Barclays's SMA Position: Q4 2014 in Review

Barclays sold out of SYMMETRY MEDICAL INC (SMA) in Q4 2014, closing a stake of 9,676 shares — an estimated $97K sold.

Barclays first reported a position in SMA in Q2 2013 and held it in 6 quarters. The position peaked at $537K in Q4 2013. 0 funds tracked by Wall St. Rank hold SMA as of Q4 2014.

Barclays reported no remaining SYMMETRY MEDICAL INC position as of Q4 2014 after selling out during the quarter.
Barclays sold 9,676 SYMMETRY MEDICAL INC shares in Q4 2014, an estimated $97K.
Barclays first reported a position in SYMMETRY MEDICAL INC in Q2 2013 and held it in 6 quarters.
Barclays's SYMMETRY MEDICAL INC position peaked at $537K in Q4 2013.
0 funds tracked by Wall St. Rank held SYMMETRY MEDICAL INC as of Q4 2014.

Based on Barclays's 13F filing for Q4 2014, filed 13 Feb 2015.